Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06178978 · ClinicalTrials.gov registry record
Device for Age-related Macular Degeneration (AMD)
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 31
- Enrollment target
NCT06178978 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 31 participants.
The verdict
NCT06178978 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 31 participants
- Enrollment target
Study Summary
This study involves user acceptability and feedback of KalEYEdoscope, a digital, handheld device utilizing shape-discrimination hyperacuity to distinguish the severity of age-related macular degeneration (AMD).
Interventions
- DEVICE KalEYEdoscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-03-10 |
| Est. Completion | 2022-03-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06178978
The ClinicalTrials.gov registry entry for NCT06178978 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KalEYEdoscope is the first listed.
NCT06178978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06178978 about?
NCT06178978 is a clinical study titled "Device for Age-related Macular Degeneration (AMD)". This study involves user acceptability and feedback of KalEYEdoscope, a digital, handheld device utilizing shape-discrimination hyperacuity to distinguish the severity of age-related macular degeneration (AMD).
What is the current status of trial NCT06178978?
This trial is currently completed. The enrollment target is 31 participants. The study started on 2022-03-10. Estimated completion is 2022-03-25.
What interventions are being tested in trial NCT06178978?
The interventions under investigation include: KalEYEdoscope (DEVICE).
Who is sponsoring clinical trial NCT06178978?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.